3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
37
Prostatic Neoplasms
19
Multiple Myeloma
17
Neoplasm Metastasis
14
Osteoporosis
8
Neuroblastoma
6
Pain
5
Osteosarcoma
5
Neoplasms, Plasma Cell
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Sarcoma, Ewing
3
Bone Diseases, Metabolic
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteonecrosis
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Neoplasms
2
Humoral Hypercalcemia Of Malignancy
2
Giant Cell Tumor of Bone
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Adenocarcinoma
2
Interventions
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metastatic Breast Cancer With Bone Involvement
×
Zoledronic Acid
×
Clear all
NCT01344967
2015-06-23
SuBDuE
University Health Network, Toronto
Phase 2/3
Completed
21 enrolled